retatrutide b12 deficiency vs. Tirzepatide: The New Contender vs. the Current Leader Retatrutide Side Effects Guide: 21

Description

Retatrutide (2026) Semaglutide Mechanism: GLP-1 receptor agonist FDA Status: Approved for diabetes and weight management Expected Weight Loss: 1520% body weight Administration: Weekly injection Onset: Appetite changes within first few weeks Cost: Membership pricing at Better Med Spa see plans Tirzepatide Mechanism: Dual GIP + GLP-1 receptor agonist FDA Status: Approved for diabetes and weight management Expected Weight Loss: Up to 22% body weight Administration: Weekly injection Onset: Often faster appetite suppression Cost: Membership pricing at Better Med Spa see plans Retatrutide Mechanism: Triple agonist (GLP-1 + GIP + Glucagon) FDA Status: NOT approved investigational only Expected Weight Loss: Early data suggests very potent effects (up to 24% in trials) Administration: Weekly injection (investigational protocols) Onset: Under investigation Cost: Not yet available What Are Semaglutide, Tirzepatide, and Retatrutide

Trial outcomes don't tell any individual patient exactly what will happen to them

2190

Tirzepatide is unique because it targets both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors, making it a dual agonist

Thus, it seems unlikely that these improvements in blood pressure can be completely ascribed to decreases in body weight that were progressive over the 26-week duration of each study